A Year in Review on Tuberculosis and Non-tuberculous Mycobacteria Disease: A 2025 Update for Clinicians and Scientists.

Q1 Medicine

Pathogens and Immunity Pub Date : 2025-03-02 eCollection Date: 2025-01-01 DOI:10.20411/pai.v10i2.791

Christoph Lange, Graham Bothamley, Gunar Günther, Lorenzo Guglielmetti, Irina Kontsevaya, Liga Kuksa, Berit Lange, Natalie Lorent, Francesca Saluzzo, Martina Sester, Marc Tebruegge, Simone Tunesi, Conor Tweed

{"title":"A Year in Review on Tuberculosis and Non-tuberculous Mycobacteria Disease: A 2025 Update for Clinicians and Scientists.","authors":"Christoph Lange, Graham Bothamley, Gunar Günther, Lorenzo Guglielmetti, Irina Kontsevaya, Liga Kuksa, Berit Lange, Natalie Lorent, Francesca Saluzzo, Martina Sester, Marc Tebruegge, Simone Tunesi, Conor Tweed","doi":"10.20411/pai.v10i2.791","DOIUrl":null,"url":null,"abstract":"Background: In the field of tuberculosis and non-tuberculous mycobacterial (NTM) disease we are looking back on an exciting year 2024 with more than 10,000 publications listed in PubMed.Methods: Our aim, to review the scientific literature of the year 2024, is challenged by the enormous number of publications. Therefore, if your article is not included or your favorite field of mycobacteriology not covered, please forgive us. Our \"Year in Review\" is very much clinically oriented with lesser emphasis on basic science, microbiology, and biotechnology.Results: Members of the steering committee of the Tuberculosis Network European Trials group (TBnet; www.tbnet.eu) report on 139 publications in the fields of epidemiology, prevention, diagnosis, and treatment of tuberculosis and NTM diseases published in 2024 that we found particularly important. We report publications separately for tuberculosis in children and adults and for NTM disease and provide a brief overview of newer technologies in the diagnostic pipeline. Furthermore, we summarize priorities for tuberculosis and NTM disease research, development, and implementation, all of which represent the perspective of our combined clinical experience.Conclusions: This Year in Review provides a concise summary of the clinically relevant highlights of the published literature in tuberculosis and NTM diseases in 2024.","PeriodicalId":36419,"journal":{"name":"Pathogens and Immunity","volume":"10 2","pages":"1-45"},"PeriodicalIF":0.0000,"publicationDate":"2025-03-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11888605/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pathogens and Immunity","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.20411/pai.v10i2.791","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

Abstract

Background: In the field of tuberculosis and non-tuberculous mycobacterial (NTM) disease we are looking back on an exciting year 2024 with more than 10,000 publications listed in PubMed.

Methods: Our aim, to review the scientific literature of the year 2024, is challenged by the enormous number of publications. Therefore, if your article is not included or your favorite field of mycobacteriology not covered, please forgive us. Our "Year in Review" is very much clinically oriented with lesser emphasis on basic science, microbiology, and biotechnology.

Results: Members of the steering committee of the Tuberculosis Network European Trials group (TBnet; www.tbnet.eu) report on 139 publications in the fields of epidemiology, prevention, diagnosis, and treatment of tuberculosis and NTM diseases published in 2024 that we found particularly important. We report publications separately for tuberculosis in children and adults and for NTM disease and provide a brief overview of newer technologies in the diagnostic pipeline. Furthermore, we summarize priorities for tuberculosis and NTM disease research, development, and implementation, all of which represent the perspective of our combined clinical experience.

Conclusions: This Year in Review provides a concise summary of the clinically relevant highlights of the published literature in tuberculosis and NTM diseases in 2024.

查看原文本刊更多论文

结核病和非结核分枝杆菌疾病的一年回顾：临床医生和科学家的2025年更新

背景：在结核病和非结核分枝杆菌（NTM）疾病领域，我们正在回顾令人兴奋的2024年，PubMed上列出了10,000多篇出版物。方法：我们的目标是回顾2024年的科学文献，受到大量出版物的挑战。因此，如果您的文章没有被包括在内，或者您最喜欢的分枝杆菌学领域没有被包括在内，请原谅我们。我们的“年度回顾”以临床为主，较少强调基础科学、微生物学和生物技术。结果：结核病网络欧洲试验组（TBnet）指导委员会成员；www.tbnet.eu)关于流行病学、预防、诊断和治疗结核病和NTM疾病领域的139份出版物的报告，我们认为这些出版物在2024年出版特别重要。我们分别报道儿童和成人结核病以及NTM疾病的出版物，并简要概述诊断管道中的新技术。此外，我们总结了结核病和NTM疾病研究、开发和实施的重点，所有这些都代表了我们综合临床经验的观点。结论：本年度综述简要总结了2024年结核病和NTM疾病已发表文献的临床相关亮点。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊